Beruflich Dokumente
Kultur Dokumente
Is Treatable
Theoharis C. Theoharides,
MS, MPhil, PhD, MD, FAAAAI
Professor of Pharmacology, Internal Medicine and Psychiatry
Director, Molecular Immunopharmacology and Drug Discovery
Tufts University School Medicine, Boston, MA, USA
drtheoharides@gmail.com
www.mastcellmaster.com
www.autismfreebrain.org
www.brain-gate.org
Disclosures
Now 1 in 45 children
ADD/ADHD
Allergies/Food intolerance
Gastrointestinal problems
Subgroups Mitochondrial dysfunction
PANDAS (Pediatric Autoimmune Neuropsychiatric
Disorders Associated With Streptococcal Infections)
PTEN mutations (large skull, headaches)
Seizures
1
Presenting Behavior
Suggestive of Autism
No response when calling name
Isolation
No group play
Loss of vocabulary
Rigid routines
Lack of imaginative play
Inability to follow directions
Anxiety
Intolerance to stress
Repetitive non-purposeful
movements
Hyperactivity
Tantrums
Tip-toeing
Hand flapping
Intolerance to sensory overload
Strange food habits
4/8/2016 Copyright by Dr. TC Theoharides 4
Gestational Perinatal
Excessive oxytocin to induce labor
Allergies/Asthma
Autoimmune diseases High fever
Diabetes Incubation/maternal separation stress
Infection Infection
Low Vitamin D Low birth weight
Pre-eclampsia
Perinatal anoxia
Psoriasis
Psychotropic drug use Preterm birth
Stress
2
Mast Cell Activation
Diencephalon
(coordinates sensory input and emotions)
3
Croen et al. Arch Pediatr Adolesc Med 2005;159:151-7.
Autism Spectrum
Disorders and
Mastocytosis
Theoharides TC. Int J Immunopathol Pharmacol.
2009 Oct-Dec;22(4):859-65.
The risk of autism was 10 times
higher than in the general population
4/8/2016
. Copyright by Dr. TC Theoharides 12
4
4/8/2016 Copyright by Dr. TC Theoharides 13
14
4/8/2016 Copyright by Dr. TC Theoharides
5
4/8/2016 Copyright by Dr. TC Theoharides 16
6
4/8/2016 Copyright by Dr. TC Theoharides 19
Mast cell
Neuron
Microglia
IL-6, TNF
7
How Can Stress Contribute to
Inflammation of the Brain?
8
30 minutes restraint stress
mouse 200
*
100
tv 99Tc-G
50
MNCs
AC133 mAb
RBCs
9
Immunocytochemistry of CRH-R in human
mast cells
-
A C D E
A B BD
F
E F
G
10
The Peptide Neurotensin Can Trigger
Inflammation of the Brain
11
50
40
VEGF
30
20
10
0
control 1nM 10nM 100nM 1uM
CRH
C) D)
12
4/8/2016 Copyright by Dr. TC Theoharides 37
Treatment
13
Most Countries Use Psychotropic Drugs in
Children with ASDs
Luteolin
(3,4,5,7-tetrahydroxyflavone)
70
*
60
50
40
30
20
10
0
Histamine Tryptase IL-6 IL-8 TNF-alpha
14
4/8/2016 Copyright by Dr. TC Theoharides 43
15
4/8/2016 Copyright by Dr. TC Theoharides 46
16
Methoxyluteolin Inhibits Inflammatory
Molecule Release from Human Microglia
Calcium
influx via
receptor
mast cell PI3K PTEN
Mast cell
activation
number
AKT 1-Control 2-Rapamycin 3-Methoxyluteolinteolin
Rapamycin
mTORC1
Mast cell Luteolin
number
17
GentleDerm
Ingredients: Water, organic aloe barbadensis leaf juice, olea europea (olive) fruit oil,
TM glycerin, organic helianthus annuus (sunflower) seed oil, steareth-21, stereath-2, cetyl
alcohol, stearyl alcohol, glyceryl stearate, lanolin, tetramethoxyflavone, sodium benzoate,
quaternium-15, disodium EDTA, magnesium chloride, honey, sodium chloride, potassium
A novel, hypoallergenic, anti-oxidant, flavonoid lotion chloride, tetrahexyldecyl ascorbate, origanum vulgare oil, disodium phosphate
for dry, irritated or sensitive skin
Made for Algonot, LLC, 5111 Ocean Bvd-Suite J
Hydrates-NourishesSoothes-Rejuvenates-Repairs Sarasota, FL 34242, USA-Toll Free 1-800-254-6668
Let Nature Calm Your SkinTM
Net weight 2 oz (56.7 gm) www.gentlederm.com
A B C D
Photos of lesional skin areas. Areas were photographed before (upper panels) and after (lower panels)
using GentleDerm twice daily for two weeks. (A,B) eczema: (A) face of a 51 year-old female patient with
mast cell activation syndrome and (B) abdomen of 43 year-old female patient with mast cell activation syndrome;
(C,D) psoriasis: (C) leg of a 47 year-old male patient with indolent systemic mastocytosis and (D) hand of
39 year-old female patient with mast cell activation syndrome.
Mast Cell
Lut & Methlut
Neurons
Inflammatory
H mediators
Treatment Approaches
Reduce anxiety/pressure
Limit sensory overload
Start speech, music and work support
Correct vitamin deficiencies
Supplement methyl donors (glutathione, SAMe, NAC)
Eliminate food intolerances
Reduce allergies
Add anti-oxidants (Omega-3, sulforaphane)
Address inflammation (luteolin, methoxyluteolin)
18
Research Funding:
DK62861
AR47652
NS071361
NS55681
AR60951
NS66205
Autism Research
Collaborative
National Autism
Association
Safe Minds
Autism Research
Institute
Jane B Johnson Fnd.
drtheoharides@gmail.com
www.mastcellmaster.com
www.autismfreebrain.org
www.brain-gate.org
4/8/2016 Copyright by Dr. TC Theoharides 55
19